King of Prussia, PA, United States of America

Vincent J Colandrea

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 10 EPO patents. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vincent J Colandrea. Retrieved from https://idiyas.com/inventor/vincent-j-colandrea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vincent J Colandrea: Innovator in NRF2 Activation

Introduction

Vincent J Colandrea is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of NRF2 activators. His work focuses on innovative compounds that have the potential to impact health and disease management.

Latest Patents

Colandrea holds a patent for "Bisaryl amides as NRF2 activators." This invention relates to bisaryl amide analogs, pharmaceutical compositions containing them, and their use as NRF2 activators. The invention specifically addresses bisaryl heterocycles of Formula (I), showcasing his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Colandrea has worked with prominent companies in the pharmaceutical industry. He has been associated with GlaxoSmithKline Intellectual Property Development Limited and Fimbrion Therapeutics, Inc. His experience in these organizations has contributed to his development as an inventor and researcher.

Collaborations

Colandrea has collaborated with notable professionals in his field, including James Francis Callahan and Anthony William James Cooper. These partnerships have likely enhanced his research and innovation capabilities.

Conclusion

Vincent J Colandrea is a distinguished inventor whose work on NRF2 activators demonstrates his commitment to advancing pharmaceutical science. His contributions are valuable to the ongoing development of therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…